Changes in properties of serine 129 phosphorylated α-synuclein with progression of Lewy-type histopathology in human brains-Reference-Cited by-同舟云学术

Changes in properties of serine 129 phosphorylated α-synuclein with progression of Lewy-type histopathology in human brains

Published:2013-02 Issue: Volume:240 Page:190-204
ISSN:0014-4886
Container-title:Experimental Neurology
language:en
Short-container-title:Experimental Neurology

Author:

Walker Douglas G.,Lue Lih-Fen,Adler Charles H.,Shill Holly A.,Caviness John N.,Sabbagh Marwan N.,Akiyama Haruhiko,Serrano Geidy E.,Sue Lucia I.,Beach Thomas G.

Funder

Michael J. Fox Foundation for Parkinson's research

National Institute of Neurological Disorders and Stroke

National Institute on Aging

Arizona Department of Health Services

Arizona Biomedical Research Commission

Publisher

Elsevier BV

Subject

Developmental Neuroscience,Neurology

Reference56 articles.

1. Staging/typing of Lewy body related alpha-synuclein pathology: a study of the BrainNet Europe Consortium;Alafuzoff;Acta Neuropathol.,2009

2. Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease;Anderson;J. Biol. Chem.,2006

3. alpha-Synuclein: membrane interactions and toxicity in Parkinson's disease;Auluck;Annu. Rev. Cell Dev. Biol.,2010

4. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies;Baba;Am. J. Pathol.,1998

5. The N-terminus of the intrinsically disordered protein alpha-synuclein triggers membrane binding and helix folding;Bartels;Biophys. J.,2010

Cited by 124 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Galantamine suppresses α-synuclein aggregation by inducing autophagy via the activation of α7 nicotinic acetylcholine receptors;Journal of Pharmacological Sciences;2024-10

2. Serum phosphorus levels associated with nigrostriatal dopaminergic deficits in drug-naïve Parkinson's disease;Journal of the Neurological Sciences;2024-09

3. Biosensors for Parkinson’s Disease: Where Are We Now, and Where Do We Need to Go?;ACS Sensors;2024-08-27

4. Physiological roles of α-synuclein serine-129 phosphorylation – not an oxymoron;Trends in Neurosciences;2024-07

5. Disease progression modelling reveals heterogeneity in trajectories of Lewy-type α-synuclein pathology;Nature Communications;2024-06-15